Climb Bio, Inc. (CLYM) Earnings Per Share (EPS)
Climb Bio, Inc. (CLYM) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$4.24 |
| 2022-12-31 | -$1.72 |
| 2023-12-31 | -$1.30 |
| 2024-12-31 | -$1.53 |
| 2025-12-31 | -$0.88 |
How CLYM compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| GOSS | Gossamer Bio Inc. | -$0.75 |
| EOLS | Evolus Inc. | -$0.80 |
| ALLO | Allogene Therapeutics Inc. | -$0.87 |
| ALT | Altimmune Inc. | -$1.00 |
| BNTC | Benitec Biopharma Inc. | -$1.05 |
These are five companies in the same sector as CLYM with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Climb Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CLYM")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CLYM | $17.34 | -0.29% | 1.29M |
| 3 | ||||
| 4 | ||||
| 5 |